Skip to content
Subscriber Only

Fujifilm Plans Bigger Global Push Into Complex Biologic Drugs

  • Fujifilm aims for sales of 100 billion yen from drug business
  • Photofilm maker has expanded into health care in recent years

Fujifilm Holdings Corp., the 83-year-old Japanese company that got its start selling photofilm, is boosting its drug manufacturing capacity in the U.S. and U.K. and looking to acquire factories to make more complex biopharmaceutical therapies.

The Japanese company, which has in recent years diversified into health care, is aiming for sales of 100 billion yen ($921 million) by the year ending March 2024 from its contract manufacturing business that mass produces medicines for international drugmakers.